S
Sequentia Biotech
Sequentia Biotech developed MICK, a digital decision support system helping healthcare professionals in integrating microbiome analysis into clinical practice
About Sequentia Biotech
Operator of a bioinformatics company intended to transform omics data into knowledge. The company collaborates with research centers, universities and businesses to offer cloud software, custom software and bioinformatics consulting services for healthcare, pharma, agriculture, industry and environment, enabling clients to utilize omics sciences for achieving a breakthrough in the fields of human health, agriculture and the environment. Keywords: Pharmaceuticals and Biotechnology, Bioinformatics, Bioinformatics Analysis, Bioinformatics Company, Bioinformatics Data, Bioinformatics Research, Bioinformatics System.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2013
- Headquarters
- Barcelona, Spain
- Employees
- 48
- Open positions
- None listed
- Dealroom signal
- 67.5/100
- Industry
- Health
- Sub-industry
- BioTechnology, Health Platform
- Sector
- Biotech & Life Sciences, Analytics, Biotechnology, Genetics and genomics, Molecular Biology, Core AI, Precision Medicine
- Technology
- Artificial Intelligence, Big Data, Machine Learning
- Business model
- SaaS
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES AOther financing | Sep 2024 | $11M | $44M | Seventure Partners · EIC Fund | ↗ |
| GRANTOther financing | Oct 2021 | $2.2M | — | European Innovation Council | — |
Financials
Revenue, earnings and other financial measures where available. Years marked “E” are estimates.
Growth signals
Latest recorded traffic for Sequentia Biotech is 2.6K monthly website visits, up 4% over the last three months. Sequentia Biotech's team grew 2.1% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed1 investor entered at this stage
European Innovation Council
Series A2 investors entered at this stage
EIC Fund
Seventure Partners
Other known investors2 additional known investors
Centre for Genomic Regulation
Centre for Research in Agricultural Genomics
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Sequentia Biotech on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Sequentia Biotech’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.







